IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience

BACKGROUND: Heterozygous isocitrate dehydrogenase (IDH) mutations occur in about half of conventional central bone chondrosarcomas (CCBC). Aim of this study was to assess the frequency and prognostic impact of IDH mutations in high grade CCBC patients. METHODS: 64 patients with G2 and G3 CCBC were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Setola, Elisabetta, Benini, S., Righi, A., Gamberi, G., Carretta, E., Ferrari, C., Avnet, S., Palmerini, E., Magagnoli, G., Gambarotti, M., Lollini, P. L., Cesari, M., Cocchi, S., Paioli, A., Longhi, A., Scotlandi, K., Laginestra, M. A., Donati, D. M., Baldini, N., Ibrahim, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521511/
https://www.ncbi.nlm.nih.gov/pubmed/37752419
http://dx.doi.org/10.1186/s12885-023-11396-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521511/
https://www.ncbi.nlm.nih.gov/pubmed/37752419
http://dx.doi.org/10.1186/s12885-023-11396-y

Ejemplares similares